Salubrious effects of lipoic acid against adriamycin-induced clastogenesis and apoptosis in Wistar rat bone marrow cells

Toxicology

Volumn 222, Issue 3, 2006, Pages 225-232

  Prahalathan, C ^a   Selvakumar, E ^a   Varalakshmi, P ^a   Kumarasamy, P ^b   Saravanan, R ^b  

^a UNIVERSITY OF MADRAS   (India)

^b MADRAS VETERINARY COLLEGE   (India)

Author keywords

Adriamycin; Apoptosis; Bone marrow; Chromosomal aberrations; DNA damage; Lipoic acid; Micronucleus

Indexed keywords

CLASTOGEN; DOXORUBICIN; THIOCTIC ACID;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD; BODY WEIGHT; BONE MARROW CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA STRAND BREAKAGE; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; GENOTOXICITY; MALE; MICRONUCLEUS TEST; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; BONE MARROW CELLS; CHROMOSOME ABERRATIONS; DNA DAMAGE; DOXORUBICIN; MALE; MICRONUCLEUS TESTS; PROTECTIVE AGENTS; RATS; RATS, WISTAR; THIOCTIC ACID;

ANIMALIA; RATTUS NORVEGICUS;

EID: 33646083252     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2006.02.015     Document Type: Article

References (50)

1. Agostini F.D., Izzotti A., Balansky R.M., Bennicelli C., and Flora S.D. Modulation of apoptosis by cancer chemopreventive agents. Mutat. Res. 591 (2005) 173-186
2. Antunes L.M., Araujo M.C., Dias F.L., and Takahashi C.S. Modulatory effects of curcumin on the chromosomal damage induced by doxorubicin in Chinese hamster ovary cells. Teratog. Carcinog. Mutagen. 19 (1999) 1-8
3. Antunes L.M., and Takahashi C.S. Effects of high doses of Vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells. Mutat. Res. 419 (1998) 137-143
4. Au W.W., and Hsu T.C. The genotoxic effects of adriamycin in somatic and germinal cells of the mouse. Mutat. Res. 79 (1980) 351-361
5. Baumgartner A., Schmid T.E., Cemeli E., and Anderson D. Parallel evaluation of doxorubicin-induced genetic damage in human lymphocytes and sperm using the comet assay and spectral karyotyping. Mutagenesis 19 (2004) 313-318
6. Berlin V., and Haseltine W.A. Reduction of adriamycin to a semiquinone-free radical by NADPH cytochrome P-450 reductase produces DNA cleavage in a reaction mediated by molecular oxygen. J. Biol. Chem. 256 (1981) 4747-4756
7. Birnboim H.C. Fluorometric analysis of DNA unwinding to study strand breaks and repair in mammalian cells. Methods Enzymol. 186 (1990) 550-555
8. Biswas S.J., Pathak S., and Khuda-Bukhsh A.R. Assessment of the genotoxic and cytotoxic potential of an anti-epileptic drug, phenobarbital, in mice: a time course study. Mutat. Res. 563 (2004) 1-11
9. Bustamante J., Slater A.F., and Orrenius S. Antioxidant inhibition of thymocyte apoptosis by dihydrolipoic acid. Free Radic. Biol. Med. 19 (1995) 339-347
10. Criswell K.A., Krishna G., Zielinski D., Urda G.A., Theiss J.C., Juneau P., and Bleavins M.R. Use of acridine orange in: flow cytometric evaluation of erythropoietic cytotoxicity. Mutat. Res. 414 (1998) 49-61
11. Cullinane C., Cutts S.M., Panousis C., and Phillips D.R. Interstrand cross-linking by adriamycin in nuclear and mitochondrial DNA of MCF-7 cells. Nucleic Acids Res. 28 (2000) 1019-1025
12. Deepa P.R., and Varalakshmi P. Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 217 (2006) 176-183
13. Devasagayam T.P., Subramanian M., Pradhan D.S., and Sies H. Prevention of singlet oxygen-induced DNA damage by lipoate. Chem. Biol. Int. 86 (1993) 79-92
14. Dhawan A., Kayani M.A., Parry J.M., Parry E., and Anderson D. Aneugenic and clastogenic effects of doxorubicin in human lymphocytes. Mutagenesis 18 (2003) 487-490
15. Foglesong P.D., Reckord C., and Swink S. Doxorubicin inhibits human DNA topoisomerase I. Cancer Chemother. Pharmacol. 30 (1992) 123-125
16. Gewirtz D.A. A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicin. Biochem. Pharmacol. 57 (1999) 727-741
17. Goldenberg G.J., Wang H., and Blair G.W. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia. Cancer Res. 46 (1986) 2978-2983
18. Gulkac M.D., Akpinar G., Ustun H., and Ozon Kanli A. Effects of Vitamin A on doxorubicin-induced chromosomal aberrations in bone marrow cells of rats. Mutagenesis 19 (2004) 231-236
19. Gutteridge J.M., and Toeg D. Adriamycin-dependent damage to deoxyribose: a reaction involving iron, hydroxyl and semiquinone free radicals. FEBS Lett. 149 (1982) 228-232
20. Hannun Y.A. Apoptosis and the dilemma of cancer chemotherapy. Blood 89 (1997) 1845-1853
21. Jagetia G.C., and Aruna R. Correlation between cell survival and micronuclei-induction in HeLa cells treated with adriamycin after exposure to various doses of γ-radiation. Toxicol. Lett. 115 (2000) 183-193
22. Jagetia G.C., and Nayak V. Micronuclei-induction and its correlation to cell survival in HeLa cells treated with different doses of adriamycin. Cancer Lett. 110 (1996) 123-128
23. Kagan V.E., Shvedova A., Serbinova E., Khan S., Swanson C., Powell R., and Packer L. Dihydrolipoic acid-a universal antioxidant both in the membrane and in the aqueous phase. Biochem. Pharmacol. 44 (1992) 1637-1649
24. Kocak N., Ustun H., Gulkac M.D., Kanli A.O., Borazan A., and Yilmaz A. Effects of 10alpha, 25-dihydroxyvitamin D3 on doxorubicin-induced chromosomal aberrations in rat bone marrow cells. Acta Oncol. 43 (2004) 204-248
25. Morelli D., Menard S., Colnaghi M.I., and Basari A. Oral administration of anti-doxorubicin monoclonal antibody prevents chemotherapy-induced gastrointestinal toxicity in mice. Cancer Res. 56 (1996) 2082-2085
26. Nakagawa I., Nishi E., Naganuma A.A., and Imura N. Effect of preinduction of metallothionein synthesis on clastogenicity of anticancer drugs in mice. Mutat. Res. 348 (1995) 37-43
27. Navari-Izzo F., Quartacci M.F., and Sgherri C. Lipoic acid: a unique antioxidant in the detoxification of activated oxygen species. Plant Physiol. Biochem. 40 (2002) 463-470
28. Neri M., Fucic A., Knudsen L.E., Lando C., Merlo F., and Bonassi S. Micronuclei frequency in children exposed to environmental mutagens: a review. Mutat. Res. 544 (2003) 243-254
29. Noviello E., Aluigi M.G., Cimoli G., Rovini E., Mazzoni A., Parodi S., De Sessa F., and Russo P. Sister-chromatid exchanges, chromosomal aberrations and cytotoxicity produced by topoisomerase II-targeted drugs in sensitive (A2780) and resistant (A2780-DX3) human ovarian cancer cells: correlations with the formation of DNA double-strand breaks. Mutat. Res. 31 (1994) 21-29
30. Olsen A.K., Lindeman B., Wiger R., Duale N., and Brunborg G. How do male germ cells handle DNA damage?. Toxicol. Appl. Pharmacol. 207 (2005) 521-531
31. Packer L., Witt E.H., and Tritschler H.J. Alpha-lipoic as biological antioxidant. A review. Free Radic. Biol. Med. 19 (1999) 227-250
32. Palmeira C.M., Serrano J., Kuehl D.W., and Wallace K.B. Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin. Biochim. Biophys. Acta 1321 (1997) 101-106
33. Papadapoulou L.C., and Tsiftsoglou A.S. Effects of hemin on apoptosis, suppression of cytochrome c oxidase gene expression, and bone-marrow toxicity induced by doxorubicin (adriamycin). Biochem. Pharmacol. 52 (1996) 713-722
34. Preston R.J., Dean B.J., Galloway S., Holden H., McFee A.F., and Shelby M. Mammalian in vivo cytogenetic assays. Analysis of chromosome aberrations in bone marrow cells. Mutat. Res. 189 (1987) 157-165
35. Rao V.K., Knutsen T., Ried T., Wangsa D., Flynn B.M., Langham G., Egorin M.J., Cole D., Balis F., Steinberg S.M., Bates S., and Fojo T. The extent of chromosomal aberrations induced by chemotherapy in non-human primates depends on the schedule of administration. Mutat. Res. 583 (2005) 105-119
36. Rapozzi V., Zorzet S., Comelli M., Mavelli I., Perssin L., and Giraldi T. Melatonin decreases bone marrow and lymphatic toxicity of adriamycin in mice bearing tlx5 lymphoma. Life Sci. 63 (1998) 1701-1713
37. Rosselli F., Zaccaro L., Venturi M., and Rossi A.M. Persistence of drug-induced chromosome aberrations in peripheral blood lymphocytes of the rat. Mutat. Res. 232 (1990) 107-114
38. Satoh M., Naganuma A., and Imura N. Modulation of adriamycin toxicity by tissue-specific induction of metallothionein synthesis in mice. Life Sci. 67 (2000) 627-634
39. Sawyer D.B., Fukazawa R., Arstall M.A., and Kelly R.A. Daunorubicin-induced apoptosis in rat cardiac myocytes is inhibited by dexrazoxane. Circ. Res. 84 (1999) 257-265
40. Schmid W. The micronucleus test. Mutat. Res. 31 (1975) 9-15
41. Scott B.C., Aruoma O.I., Evans P.J., O'Neill C., van der Vliet A., Cross C.E., Tritschler H., and Halliwell B. Lipoic and dihydrolipoic acids as antioxidants: a critical evaluation. Free Radic. Res. 20 (1994) 119-133
42. Selvakumar E., Prahalathan C., Sudharsan P.T., and Varalakshmi P. Protective effect of lipoic acid on micronuclei induction by cyclophosphamide. Arch. Toxicol. 80 (2006) 115-119
43. Skladanowski A., and Konopa J. Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells. Biochem. Pharmacol. 46 (1993) 375-382
44. Suzuki Y.J., Tsuchiya M., and Packer L. Antioxidant activities of dihydrolipoic acid and its structural homologues. Free Radic. Res. Commun. 18 (1993) 115-122
45. Tewey K.M., Rowe T.C., Yang L., Halligan B.D., and Liu L.F. Adriamycin-induced DNA damage mediated by mammalian topoisomerase II. Science 226 (1984) 466-468
46. Tohamy A.A., El-Ghor A.A., El-Nahas S.M., and Noshy M.M. β-Glucan inhibits the genotoxicity of cyclophosphamide, adriamycin and cisplatin. Mutat. Res. 541 (2003) 45-53
47. Tritton T.R., and Yee G. The anticancer agent adriamycin can be actively cytotoxic without entering the cells. Science 217 (1982) 248-250
48. van Engeland M., Nieland L.J., Ramaekers F.C., Schutte B., and Reutelingsperger C.P. Annexin V-affinity assay: a review on an apoptosis detection system based on phosphatidylserine exposure. Cytometry 31 (1998) 1-9
49. Vermes I., Haanen C., Steffens-Nakken H., and Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. J. Immunol. Methods 184 (1995) 39-51
50. Yamanaka S., Tatsumi T., Shiraishi J., Mano A., Keira N., Matoba S., Asayama J., Fushiki S., Fliss H., and Nakagawa M. Amlodipine inhibits doxorubicin-induced apoptosis in neonatal rat cardiac myocytes. J. Am. Coll. Cardiol. 41 (2003) 870-878